Silver Book Fact

In the absence of antihypertensive drug therapy, there would have been an estimated 572,000 more hospital discharges for stroke in 2002, and 261,000 more discharges for myocardial infarction. The estimated hospital discharges avoided represent a 38% reduction in discharges for stroke, and a 25% reduction in discharges for myocardial infarction; compared to preductions with untreated blood pressure.

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Greater use of clot-busting drug t-PA in ischemic stroke patients could save the health care system over $100 million a year.  
  • Cost-effectiveness of SAVR
    The cost-effectiveness ratio for surgical aortic valve replacement (SAVR), compared to no surgery, was estimated at $13,528 per quality-adjusted life year (QALY) (~$17,225 in 2017 dollars).  
  • Savings associated with t-PA treatment for ischemic stroke patients
    A $600 net savings is associated with each ischemic stroke patient treated with t-PA. In 2005, only 2% of all ischemic stroke patients received t-PA. If that percentage was increased…  
  • Increased use of a blood-thinning drug prevents 40,000 strokes every year in the U.S.  
  • In 2005, 2,125 heart transplantations were performed in the U.S.